Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000007895
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
||
|
NDF-RT |
N0000175531
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
||
|
NCI_THESAURUS |
C2140
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
||
|
WHO-VATC |
QB06AA03
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
||
|
FDA ORPHAN DRUG |
546516
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
||
|
WHO-ATC |
B06AA03
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
||
|
FDA ORPHAN DRUG |
769220
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1201636
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
HYALURONIDASE
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
SUB02552MIG
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
C87576
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
2108
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
9001-54-1
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
232-614-1
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
5464
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
8KOG53Z5EM
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
m6067
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
578350
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
ALTERNATIVE | |||
|
5033
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
DB14740
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
8KOG53Z5EM
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY | |||
|
D006821
Created by
admin on Fri Dec 15 19:51:19 GMT 2023 , Edited by admin on Fri Dec 15 19:51:19 GMT 2023
|
PRIMARY |
All of the following components must be present:
ACTIVE MOIETY